Blogforpr

  Market Overview The Pharmaceutical Grade Isonicotinamide Market is gaining steady traction as demand for high-purity intermediates continues to rise across the global pharmaceutical industry. Isonicotinamide, a derivative of isonicotinic acid, is widely used in the synthesis of active pharmaceutical ingredients (APIs), vitamin formulations, and specialty therapeutic compounds. Pharmaceutical-grade variants are produced under stringent quality standards to meet regulatory requirements, making them essential for drug manufacturers focused on safety, efficacy, and consistency. The global Pharmaceutical Grade Isonicotinamide market size is predicted to grow from US$ 25.4 million in 2024 to US$ 33.9 million in 2030; it is expected to grow at a CAGR of 4.9% from 2024 to 2030.  Growth in chronic disease prevalence, expanding generic drug production, and increasing R&D activities are collectively supporting the market’s upward trajectory. Market Dynamics Market growth i...